Sanofi SA SAN-FR:Euronext Paris

*Data is delayed | EUR
Last | 09/17/21 EDT
81.55quote price arrow down-0.12 (-0.15%)
Volume
4,135,371
52 week range
74.92 - 91.14
Loading...
  • Open82.39
  • Day High82.77
  • Day Low81.22
  • Prev Close81.67
  • 52 Week High91.14
  • 52 Week High Date08/23/21
  • 52 Week Low74.92
  • 52 Week Low Date03/03/21

Key Stats

  • Market Cap120,028.73M
  • Shares Out1,252.54M
  • 10 Day Average Volume1.83M
  • Dividend3.20
  • Dividend Yield3.92%
  • Beta0.46
  • YTD % Change3.62

KEY STATS

  • Open82.39
  • Day High82.77
  • Day Low81.22
  • Prev Close81.67
  • 52 Week High91.14
  • 52 Week High Date08/23/21
  • 52 Week Low74.92
  • 52 Week Low Date03/03/21
  • Market Cap120,028.73M
  • Shares Out1,252.54M
  • 10 Day Average Volume1.83M
  • Dividend3.20
  • Dividend Yield3.92%
  • Beta0.46
  • YTD % Change3.62

RATIOS/PROFITABILITY

  • EPS (TTM)4.64
  • P/E (TTM)17.59
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date05/05/2021
  • Div Amount3.20
  • Split Date-
  • Split Factor-

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Sanofi SA is a healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment...
Serge Weinberg
Non-Executive Chairman
Paul Hudson Ph.D.
Chief Executive Officer
Jean-Baptiste Chasseloup De Chatillon
Chief Financial Officer
Karen Linehan J.D.
Executive Vice President
John Reed M.D., Ph.D.
Executive Vice President
Address
54 rue la Boetie
Paris
75008
France